Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world's first mRNA-based ...

A growing body of evidence suggests that long COVID (or post-COVID syndrome), a condition affecting more than 10% of people ...

The EMA approved Moderna's mRNA COVID-19 and flu vaccine, but US political battles and funding cuts threaten the future of mRNA vaccine innovation. Talha Burki reports.

A "highly mutated" COVID variant that has been detected in at least 25 states is gaining ground, according to health ...

Moderna (NASDAQ:MRNA) has agreed to resolve a patent litigation in which Alnylam Pharmaceuticals (NASDAQ:ALNY) has alleged that the delivery technology used in the company’s COVID-19 vaccine has ...